Related Experiment Video

Updated: Jun 25, 2026

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye
09:03

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye

Published on: June 20, 2015

Travoprost in children: adverse effects and intraocular pressure response

Tammy L Yanovitch1, Laura B Enyedi, Erin O Schotthoeffer

  • 1Duke University Eye Center, Durham, North Carolina, USA.

Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
|February 24, 2009
PubMed

Insights

Travoprost, a topical medication, shows minimal adverse events and can reduce intraocular pressure (IOP) in select pediatric glaucoma cases. This study highlights its potential use in children, where research is often limited.

Area of Science:

  • Ophthalmology
  • Pediatric Medicine
  • Pharmacology

Background:

  • Controlled studies on pediatric glaucoma treatments are limited.
  • The safety and effectiveness of topical medications in children can be difficult to ascertain.
  • Travoprost, available since 2001, lacks published pediatric use reports.

Purpose of the Study:

  • To evaluate the safety and effectiveness of travoprost in pediatric glaucoma.
  • To address the lack of published data on travoprost use in children.
  • To assess intraocular pressure (IOP) reduction and adverse events in pediatric patients.

Main Methods:

  • Retrospective study design.
  • Analysis of travoprost use in pediatric glaucoma patients.
  • Evaluation of adverse events and IOP changes.

Main Results:

  • Travoprost demonstrated minimal adverse events in the pediatric population.
  • The medication was effective in reducing IOP in select cases of pediatric glaucoma.
  • No significant safety concerns were identified during the study period.

Conclusions:

  • Travoprost appears to be a safe option for managing pediatric glaucoma.
  • The medication shows potential for IOP reduction in children with glaucoma.
  • Further research is warranted to confirm these findings in larger pediatric cohorts.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...